ERBB2 and non-small cell lung carcinoma: However, unlike available literature suggesting that HER2-mutant NSCLC has been shown to have lower PD-L1 expression than wild-type NSCLC (44), we discovered that cases with HER2 mutation exhibited higher PD-L1 expression at the protein level, corresponding to dense TILs.